Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments - Wikidata - awgldk - TriplyDB

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

http://www.wikidata.org/entity/Q27024117

about

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease.Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment.Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations.Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.Taming Alzheimer's disease: New perspectives, newer horizons.

P2860

Q34422469-360D2315-D662-4BBC-BEEB-214EC4F72A04 Q34629872-108F2CC9-9805-4D12-8408-78D1B99F94E5 Q35055819-97856CE5-BA51-411C-BECB-973C1FF94BC9 Q36055870-646393DB-2228-4DB9-8F4B-CEC45AADCEF8 Q36494819-905200B1-8C29-4317-8A16-402CB5A3CFC1 Q36974723-C5AC2A12-00AC-484E-8FF9-801101122A2E Q38150708-4567F01C-9F73-4B34-91A4-56A90B2A66B2 Q38690632-63BFA6AE-76A4-48D1-B25C-C472765A5F59 Q47171672-2D8313BC-1320-422F-843A-B17FF89925AE

P2860

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

http://www.wikidata.org/entity/Q27024117

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@ast

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@en

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@nl

type

label

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@ast

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@en

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@nl

prefLabel

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@ast

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@en

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@nl

P1433

Q27024117-16C7221A-F890-4CCE-B3A5-2AA75D6CBB3E

P1476

Q27024117-DB74D8CB-527B-45DF-A470-415201F25AA1

P2860

Q27024117-1E42A309-56B3-435A-88DE-CE82D15DF22C

Q27024117-4EF8175E-6603-4962-9148-79332DBA1595

Q27024117-5BCB9EB0-B631-49CC-A955-85741B4DD0DC

Q27024117-65AD5C5C-87BC-4131-855D-ED4C9623DB2A

Q27024117-72430E8C-8922-43BD-B71E-43C9FD02D67D

Q27024117-9AA9102C-55A9-4D82-A184-24C8A3A77759

Q27024117-A398233D-FBC1-4B15-9489-0E8E78338FF6

Q27024117-DB5D616F-3AFA-43EF-96A2-E48A5BD88D00

P304

Q27024117-E314C8DE-C706-4E67-BC05-6763B302D414

P31

Q27024117-2E2DFE43-F8B9-4259-BC68-74E7EEF38B16

P3181

Q27024117-B6BAB80E-6D92-4970-AB94-2047729EE37A

P356

Q27024117-2156565C-3C8A-41AF-BB7C-02098D19C021

P407

Q27024117-5C7A08F9-79FA-43F5-827A-98BE0C090BDA

P478

Q27024117-D3BAAD71-4E07-4279-AAA7-AEE75B90B1F0

P50

Q27024117-7C85749E-7770-4755-868E-06ABB89167C7

P577

Q27024117-3B679AE6-6870-4357-B920-1E899D0EFCC7

P5875

Q27024117-DC7D3047-0B22-4A0D-9CA0-A2F011A8BA49

P698

Q27024117-A1006550-2C61-4FA6-B8A3-04F1B8E8DC21

P921

Q27024117-C8449DD2-8BDE-4072-857D-68B6B2C62BE0

P932

Q27024117-4CA47691-249F-4630-9846-05A70BDA5029

P3181

P356

J.NEUROBIOLAGING.2011.09.007

P1433

Neurobiology of Aging

P1476

Fluorodeoxyglucose positron em ...... s disease-modifying treatments

@en

P2860

Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

Comparing predictors of conversion and decline in mild cognitive impairment.

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

Characterizing Alzheimer's disease using a hypometabolic convergence index.

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

P304

S44-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1150108

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEUROBIOLAGING.2011.09.007

http://www.w3.org/2001/XMLSchema#string

P407

P478

32 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51702831

http://www.w3.org/2001/XMLSchema#string

P698

21983241

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3343736

http://www.w3.org/2001/XMLSchema#string